Richard J. Kim

SVP, Commercial US, Intercept Pharmaceuticals.

Companies

Avadel PharmaceuticalsChief Commercial Officer Feb 17, 2021 to Mar 4, 2024¹
Intercept PharmaceuticalsPresident Feb 22, 2018 to Jan 5, 2021²
Intercept PharmaceuticalsSVP, Commercial US May 12, 2017 to Oct 4, 2017³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAvadel Pharmaceuticals, Chief Commercial Officer
2
SEC EDGARIntercept Pharmaceuticals, President
3
SEC EDGARIntercept Pharmaceuticals, SVP, Commercial US